PSI
AMPH icon

Pinnacle Summer Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History

Pinnacle Summer Investments’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,000
Closed -$34K – 780
2015
Q3 		$34K Hold
3,000
– – 0.01% 542
2015
Q2 		$53K Hold
3,000
– – 0.01% 311
2015
Q1 		$45K Hold
3,000
– – 0.01% 528
2014
Q4 		$36K Buy
+3,000
New +$32.7K ﹤0.01% 568

Other funds holding AMPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pinnacle Summer Investments's AMPH Position: Q4 2015 in Review

Pinnacle Summer Investments sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2015, closing a stake of 3,000 shares — an estimated $34K sold.

Pinnacle Summer Investments first reported a position in AMPH in Q4 2014 and held it in 4 quarters. The position peaked at $53K in Q2 2015. 95 funds tracked by Wall St. Rank hold AMPH as of Q4 2015.

  • Pinnacle Summer Investments reported no remaining Amphastar Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Pinnacle Summer Investments sold 3,000 Amphastar Pharmaceuticals shares in Q4 2015, an estimated $34K.
  • Pinnacle Summer Investments first reported a position in Amphastar Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Pinnacle Summer Investments's Amphastar Pharmaceuticals position peaked at $53K in Q2 2015.
  • 95 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2015.

Based on Pinnacle Summer Investments's 13F filing for Q4 2015, filed 16 Feb 2016.